Kronos Bio, Inc.
KRONDelisted Jun 20, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001741830
Kronos Bio, Inc. was delisted on Jun 20, 2025; its insiders filed their last Form 4 on Jun 20, 2025; 47 institutions reported holding it in 13F filings for Q1 2025, worth $15.8M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Kronos Bio, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 94
- +1 vs. Q1 2022
- Shares held
- 36.9M
- −2.02M (−5.2%) vs. Q1 2022
- Total value
- $134.4M
- −$147.1M (−52.3%) vs. Q1 2022
- New holders
- 21
- 31 more added
- Sold out
- 20
- 20 more reduced
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 47 | $15.8M |
| Q4 2024 | 56 | $18.7M |
| Q3 2024 | 53 | $19.7M |
| Q2 2024 | 56 | $25.6M |
| Q1 2024 | 58 | $28.2M |
| Q4 2023 | 60 | $33.4M |
| Q3 2023 | 63 | $39.3M |
| Q2 2023 | 80 | $54.3M |
| Q1 2023 | 87 | $47.3M |
| Q4 2022 | 97 | $55.9M |
| Q3 2022 | 96 | $120.8M |
| Q2 2022 | 94 | $134.4M |
| Q1 2022 | 96 | $282.0M |
| Q4 2021 | 81 | $557.8M |
| Q3 2021 | 83 | $811.6M |
| Q2 2021 | 77 | $956.8M |
| Q1 2021 | 71 | $1.05B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Kronos Bio, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Swiss National Bank | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −24,534−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −22,829−100.0% | Sold out |
| NewEdge Wealth, LLC | 0 | $0 | 0.00% | −16,180−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −13,137−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −12,400−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −11,844−100.0% | Sold out |
| Handelsbanken Fonder AB | 0 | $0 | 0.00% | −10,100−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,796−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −2,634−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −272−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −238−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| IndexIQ Advisors LLC | – | – | – | – | Not filed |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |